Long Term Optimisation of F8 Gene Mutation Screening by DHPLC
暂无分享,去创建一个
E. Seifried | H. Singer | J. Oldenburg | O. el-Maarri | M. Watzka | R. Schwaab | V. Ivaškevičius | W. Schramm | H. Brackmann | J. Graw | C. Klein | C. Müller-Reible | E. Seifried | P. Hanfland | J. Schröder | J. Oldenburg | M. Lim-Eimer
[1] Felix W. Frueh,et al. The Use of Denaturing High-Performance Liquid Chromatography (DHPLC) for the Analysis of Genetic Variations: Impact for Diagnostics and Pharmacogenetics , 2003, Clinical chemistry and laboratory medicine.
[2] J. Oldenburg. Mutation Profiling in Haemophilia A , 2001, Thrombosis and Haemostasis.
[3] J. Oldenburg,et al. Coagulation Factor IX Propeptide Mutations Causing Coumarin Hypersensitivity: Identification of Female Alanine-10 Valine Heterozygotes , 2001, Thrombosis and Haemostasis.
[4] C. Müller,et al. Evaluation of DHPLC in the analysis of hemophilia A. , 2001, Journal of biochemical and biophysical methods.
[5] M. O’Donovan,et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. , 1999, Clinical chemistry.